These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35163142)

  • 1. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.
    Pasquini S; Contri C; Merighi S; Gessi S; Borea PA; Varani K; Vincenzi F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A
    Domenici MR; Ferrante A; Martire A; Chiodi V; Pepponi R; Tebano MT; Popoli P
    Pharmacol Res; 2019 Sep; 147():104338. PubMed ID: 31276772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.
    Chiu GS; Freund GG
    Metabolism; 2014 Dec; 63(12):1491-8. PubMed ID: 25308443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Adenosine Receptors in Neurological Diseases.
    Atif M; Alsrhani A; Naz F; Imran M; Imran M; Ullah MI; Alameen AAM; Gondal TA; Raza Q
    Cell Reprogram; 2021 Apr; 23(2):57-72. PubMed ID: 33861641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Receptors in Modulation of Central Nervous System Disorders.
    Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
    Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of Adenosine Receptors: The State of the Art.
    Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
    Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
    Morin N; Di Paolo T
    Int Rev Neurobiol; 2014; 119():151-67. PubMed ID: 25175965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptor subtypes: characterization and therapeutic regulation.
    Olah ME; Stiles GL
    Annu Rev Pharmacol Toxicol; 1995; 35():581-606. PubMed ID: 7598508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimeric adenosine receptors: a device to regulate neurotransmitter release.
    Ciruela F; Ferré S; Casadó V; Cortés A; Cunha RA; Lluis C; Franco R
    Cell Mol Life Sci; 2006 Nov; 63(21):2427-31. PubMed ID: 17058035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and adenosine.
    Ribeiro JA; Sebastião AM
    J Alzheimers Dis; 2010; 20 Suppl 1():S3-15. PubMed ID: 20164566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine and Inflammation: Here, There and Everywhere.
    Pasquini S; Contri C; Borea PA; Vincenzi F; Varani K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perspectives on the therapy of neuropsychiatric diseases with adenosinergic substances].
    Erfurth A; Schmauss M
    Fortschr Neurol Psychiatr; 1995 Mar; 63(3):93-8. PubMed ID: 7759049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
    Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
    Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adenosine receptors in mood and anxiety disorders.
    van Calker D; Biber K; Domschke K; Serchov T
    J Neurochem; 2019 Oct; 151(1):11-27. PubMed ID: 31361031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic receptors in psychiatric disorders.
    Krügel U
    Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, biochemistry and function of striatal adenosine A2A receptors.
    Svenningsson P; Le Moine C; Fisone G; Fredholm BB
    Prog Neurobiol; 1999 Nov; 59(4):355-96. PubMed ID: 10501634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.
    Fredholm BB; Chen JF; Masino SA; Vaugeois JM
    Annu Rev Pharmacol Toxicol; 2005; 45():385-412. PubMed ID: 15822182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adenosine neuromodulation system in schizophrenia.
    Rial D; Lara DR; Cunha RA
    Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and the nervous system: pharmacological data and therapeutic perspectives.
    Guieu R; Dussol B; Halimi G; Bechis G; Sampieri F; Berland Y; Sampol J; Couraud F; Rochat H
    Gen Pharmacol; 1998 Oct; 31(4):553-61. PubMed ID: 9792214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.